Literature DB >> 22732499

The conserved C terminus of Claspin interacts with Rad9 and promotes rapid activation of Chk1.

Shizhou Liu1, Na Song, Lee Zou.   

Abstract

Claspin is a key mediator of the ATR-Chk1 checkpoint pathway. In response to DNA damage, Claspin interacts with Rad17 and Chk1 in a phosphorylation-dependent manner, enabling ATR to phosphorylate Chk1 efficiently. Claspin also interacts with Rad9, but how they interact and whether the interaction is functional remains unknown. Unexpectedly, our analysis of two splicing isoforms of Claspin provided an answer to these questions. The Claspin(1339) isoform contains an evolutionarily conserved C terminus, but the Claspin(1332) isoform does not. Although the transcripts encoding both Claspin isoforms coexist in HCT116 cells, Claspin(1339) is the predominant form responsible for Chk1 activation. When expressed in cells depleted of endogenous Claspin, both Claspin(1339) and Claspin(1332) are able to mediate Chk1 activation. However, the activation of Chk1 is delayed in Claspin(1332)-expressing cells compared with Claspin(1339)-expressing cells. Furthermore, only Claspin(1339) but not Claspin(1332) interacts with Rad9 efficiently. Together, these results suggest that the conserved C terminus of Claspin interacts with Rad9 and ensures timely activation of the ATR-Chk1 pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732499      PMCID: PMC3409011          DOI: 10.4161/cc.21041

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

1.  Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1.

Authors:  Akiko Kumagai; Soo-Mi Kim; William G Dunphy
Journal:  J Biol Chem       Date:  2004-09-15       Impact factor: 5.157

2.  Regulation of Claspin degradation by the ubiquitin-proteosome pathway during the cell cycle and in response to ATR-dependent checkpoint activation.

Authors:  Lara N Bennett; Paul R Clarke
Journal:  FEBS Lett       Date:  2006-07-05       Impact factor: 4.124

3.  Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation.

Authors:  Shizhou Liu; Simon Bekker-Jensen; Niels Mailand; Claudia Lukas; Jiri Bartek; Jiri Lukas
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress.

Authors:  Niels Mailand; Simon Bekker-Jensen; Jiri Bartek; Jiri Lukas
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

5.  TopBP1 activates the ATR-ATRIP complex.

Authors:  Akiko Kumagai; Joon Lee; Hae Yong Yoo; William G Dunphy
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

6.  Chk1 is required to maintain claspin stability.

Authors:  C C S Chini; J Wood; J Chen
Journal:  Oncogene       Date:  2006-02-27       Impact factor: 9.867

7.  ATRIP associates with replication protein A-coated ssDNA through multiple interactions.

Authors:  Yuka Namiki; Lee Zou
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

8.  DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system.

Authors:  Catriona A L Clarke; Paul R Clarke
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

9.  Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of Chk1 during ATR-mediated activation.

Authors:  Seong-Yun Jeong; Akiko Kumagai; Joon Lee; William G Dunphy
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

10.  Replication protein A-mediated recruitment and activation of Rad17 complexes.

Authors:  Lee Zou; Dou Liu; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-06       Impact factor: 11.205

View more
  13 in total

Review 1.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

Review 2.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

3.  CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.

Authors:  Leena Chaudhuri; Nicole D Vincelette; Brian D Koh; Ryan M Naylor; Karen S Flatten; Kevin L Peterson; Amanda McNally; Ivana Gojo; Judith E Karp; Ruben A Mesa; Lisa O Sproat; James M Bogenberger; Scott H Kaufmann; Raoul Tibes
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

4.  Pathways to chromothripsis.

Authors:  Robert Ivkov; Fred Bunz
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

5.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

6.  The ATR signaling pathway is disabled during infection with the parvovirus minute virus of mice.

Authors:  Richard O Adeyemi; David J Pintel
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

Review 7.  DNA mismatch repair and the DNA damage response.

Authors:  Zhongdao Li; Alexander H Pearlman; Peggy Hsieh
Journal:  DNA Repair (Amst)       Date:  2015-12-02

8.  HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability.

Authors:  Min Zhu; Hongchang Zhao; Ji Liao; Xingzhi Xu
Journal:  Nucleic Acids Res       Date:  2014-10-17       Impact factor: 16.971

9.  The CDK-PLK1 axis targets the DNA damage checkpoint sensor protein RAD9 to promote cell proliferation and tolerance to genotoxic stress.

Authors:  Takeshi Wakida; Masae Ikura; Kenji Kuriya; Shinji Ito; Yoshiharu Shiroiwa; Toshiyuki Habu; Takuo Kawamoto; Katsuzumi Okumura; Tsuyoshi Ikura; Kanji Furuya
Journal:  Elife       Date:  2017-12-19       Impact factor: 8.140

10.  Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy.

Authors:  Haiqin Yun; Ranran Shi; Qingrui Yang; Xiaofang Zhang; Yan Wang; Xingchen Zhou; Kun Mu
Journal:  Sci Rep       Date:  2014-12-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.